Correlation Between Wave Life and Protalix Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Wave Life and Protalix Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Wave Life and Protalix Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Wave Life Sciences and Protalix Biotherapeutics, you can compare the effects of market volatilities on Wave Life and Protalix Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Wave Life with a short position of Protalix Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Wave Life and Protalix Biotherapeutics.
Diversification Opportunities for Wave Life and Protalix Biotherapeutics
-0.84 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Wave and Protalix is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Wave Life Sciences and Protalix Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protalix Biotherapeutics and Wave Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Wave Life Sciences are associated (or correlated) with Protalix Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protalix Biotherapeutics has no effect on the direction of Wave Life i.e., Wave Life and Protalix Biotherapeutics go up and down completely randomly.
Pair Corralation between Wave Life and Protalix Biotherapeutics
Considering the 90-day investment horizon Wave Life Sciences is expected to under-perform the Protalix Biotherapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Wave Life Sciences is 1.04 times less risky than Protalix Biotherapeutics. The stock trades about -0.23 of its potential returns per unit of risk. The Protalix Biotherapeutics is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 223.00 in Protalix Biotherapeutics on November 27, 2024 and sell it today you would earn a total of 14.50 from holding Protalix Biotherapeutics or generate 6.5% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Wave Life Sciences vs. Protalix Biotherapeutics
Performance |
| Timeline |
| Wave Life Sciences |
| Protalix Biotherapeutics |
Wave Life and Protalix Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Wave Life and Protalix Biotherapeutics
The main advantage of trading using opposite Wave Life and Protalix Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Wave Life position performs unexpectedly, Protalix Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protalix Biotherapeutics will offset losses from the drop in Protalix Biotherapeutics' long position.| Wave Life vs. Arrowhead Pharmaceuticals | Wave Life vs. CytomX Therapeutics | Wave Life vs. Assembly Biosciences | Wave Life vs. Apellis Pharmaceuticals |
| Protalix Biotherapeutics vs. Corvus Pharmaceuticals | Protalix Biotherapeutics vs. Aldeyra | Protalix Biotherapeutics vs. Checkpoint Therapeutics | Protalix Biotherapeutics vs. Cidara Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |